What is the recommended treatment for shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Shingles (Herpes Zoster)

For uncomplicated shingles, start oral valacyclovir 1 gram three times daily or famciclovir 500 mg three times daily for 7-10 days, continuing until all lesions have completely scabbed. 1, 2

First-Line Antiviral Therapy

Initiate treatment as soon as possible—ideally within 48-72 hours of rash onset—though treatment beyond 72 hours still provides benefit. 1, 3

Oral Antiviral Options (Choose One):

  • Valacyclovir 1 gram three times daily for 7-10 days—preferred due to convenient dosing and superior bioavailability 1, 2

  • Famciclovir 500 mg three times daily for 7-10 days—equally effective with convenient dosing 1, 4

  • Acyclovir 800 mg five times daily for 7-10 days—effective but requires more frequent dosing, which may reduce compliance 1, 3

Critical endpoint: Continue treatment until ALL lesions have scabbed, not just for an arbitrary 7-day period. 1, 3 Treatment may need extension beyond 7 days if lesions remain active. 3

When to Escalate to Intravenous Therapy

Switch to IV acyclovir 5 mg/kg every 8 hours for: 1, 5, 3

  • Disseminated herpes zoster (multi-dermatomal or visceral involvement) 1
  • Immunocompromised patients with severe disease 5, 3
  • Facial zoster with suspected CNS involvement or severe ophthalmic disease 1
  • Any patient unable to tolerate oral medications 5

In immunocompromised patients with disseminated disease, temporarily reduce immunosuppressive medications while on IV acyclovir. 1, 3

Special Populations and Situations

Facial/Ophthalmic Involvement:

  • Requires urgent antiviral therapy due to risk of cranial nerve and vision complications 1
  • Elevate the affected area to promote drainage 1
  • Keep skin well-hydrated with emollients 1
  • Consider ophthalmology referral for any eye involvement 6

Immunocompromised Patients:

  • Require more aggressive management with consideration for IV therapy 5, 3
  • May need longer treatment duration until complete clinical resolution 5
  • Monitor closely for disseminated disease 1

Kidney Transplant Recipients:

  • Oral acyclovir or valacyclovir for uncomplicated cases 1
  • IV acyclovir with temporary immunosuppression reduction for disseminated disease 1

Adjunctive Therapies

Corticosteroids:

  • Prednisone may be considered as adjunctive therapy in select cases of severe, widespread shingles 1
  • Avoid in immunocompromised patients due to increased risk of disseminated infection 1
  • Avoid in patients with poorly controlled diabetes, history of steroid-induced psychosis, severe osteoporosis, or prior severe steroid toxicity 1

Pain Management:

  • Acute pain may require analgesics ranging from NSAIDs to narcotics 6
  • For postherpetic neuralgia: consider tricyclic antidepressants, anticonvulsants, capsaicin, or lidocaine patches 6

Critical Pitfalls to Avoid

  • Never use topical acyclovir—it is substantially less effective than oral therapy 1, 3
  • Do not stop treatment at 7 days if lesions have not completely scabbed 1, 3
  • Do not delay treatment waiting for the 72-hour window to pass—later treatment still provides benefit 1
  • Do not underdose or use inadequate treatment duration, which increases complication risk 3

Infection Control

Patients must avoid contact with susceptible individuals (those who haven't had chickenpox or vaccination) until all lesions have crusted. 1, 5 Lesion fluid contains infectious viral particles. 5

Prevention and Follow-Up

  • Recommend Shingrix (recombinant zoster vaccine) for all adults ≥50 years, regardless of prior shingles episodes 1
  • Ideally vaccinate before initiating immunosuppressive therapies 1
  • Monitor renal function during IV acyclovir therapy with dose adjustments for renal impairment 1
  • Assess for complete healing of all lesions 1, 3

References

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Shingles with Antiviral Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antiviral Therapy and Patient Management for Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.